New Knee System Offered at UC Davis Health Provides Hope for Knee Pain Sufferers

UC Davis Health pioneers cutting-edge technology for knee pain relief

UC Davis Health is among the first in the nation to offer a groundbreaking technology that provides hope for individuals suffering from knee pain. Joe Barron, who has always been active, struggled with knee pain since the 80s and had undergone numerous surgeries to address the issue. The pain was hindering his ability to walk, pivot, and maintain proper knee alignment.

Joe’s doctor recommended a new solution known as the Misha knee system, which is an implantable tool designed to act as a shock absorber for the knee. Dr. Casandra Lee, the chief of orthopedic sports medicine at UC Davis Health, referred to the device as a “game changer” tailored for individuals with mild to moderate arthritis in the inner part of the knee. The Misha knee system helps distribute the load and reduces weight on the inside part of the knee by 30%, delaying the need for a complete knee replacement.

Despite initial reservations about undergoing more surgeries, Barron decided to proceed with the Misha knee system to regain stability. The device has allowed him to perform at his best, whether it’s firefighting or spending time with his family. Dr. Lee acknowledged the necessity for more data on the long-term outcomes of the device but is optimistic that it will offer individuals like Barron the freedom to engage in their favorite activities without limitations.

Joe’s experience with this technology has provided hope for many others who suffer from similar conditions. With its ability to reduce pain and increase mobility, individuals can now live their lives without being limited by their knees.

In conclusion, UC Davis Health is leading the way in offering this innovative technology that has transformed Joe’s life and given him back his independence. As more research continues on this device’s long-term outcomes, we can expect even more positive results for those suffering from knee pain.

Leave a Reply